Biotech entity

Global assisted-dying framework

Company

pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Assisted-dying bill, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 2.5 for the same window.

Last mentioned: Aug 1, 2026

Entity pulse

Recent coverage · Global assisted-dying framework

1 story
6 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Global assisted-dying framework

pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Assisted-dying bill, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 2.5 for the same window. The 6 average consequence score is above the beat benchmark of 5.7 in the same window. Global assisted-dying framework appears in 1 tracked Biotech story from August 1, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 21 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Global assisted-dying framework. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. National Assembly gives final approval

    Lower house votes 291-241 in favor of the assisted-dying bill after years of debate.

  2. Macron commits to opening path for assisted dying

    President Macron announces his intention to legislate on end-of-life options.

Stories mentioning Global assisted-dying framework 1

Pharma Neutral

France’s 291-241 Vote Opens a New Market for 300M+ Patients Worldwide

France's historic vote to legalize assisted dying creates a new regulatory landscape for pharmaceutical companies developing end-of-life drugs. With 300 million people globally already having access, the French market offers opportunities for drug manufacturers, biotech firms, and palliative medicine innovators. Constitutional review awaits, but the pharma sector must prepare for evolving demand.

2 sources

Source: texarkanagazette.com · ksat.com

Global assisted-dying framework is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.